Pharma-Bio Serv, Inc.
PBSV
$0.60
-$0.09-13.03%
OTC PK
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -314.15% | 1,022.35% | -47.20% | 105.21% | -44.62% |
| Total Depreciation and Amortization | -4.11% | 19.69% | 9.25% | 4.73% | -0.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -259.70% | 136.90% | -429.27% | 166.10% | -426.13% |
| Change in Net Operating Assets | 190.63% | -39.50% | -1,486.84% | 93.43% | 33.29% |
| Cash from Operations | 178.42% | 29.78% | -647.83% | 111.70% | 4.34% |
| Capital Expenditure | 53.49% | -- | -- | -8,163.16% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 150.61% | -426.08% | 200.85% | -91.10% | 904.49% |
| Cash from Investing | 150.48% | -426.50% | 476.27% | -95.35% | 904.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 70.93% | -- | -- | 100.00% | 26.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 99.71% | -- | -- | 100.00% | 99.90% |
| Foreign Exchange rate Adjustments | -91.46% | 369.63% | -582.14% | 60.56% | 64.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.76% | -1,065.91% | 118.37% | -91.79% | 203.67% |